Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin provocation in systemic mastocytosis
NL-OMON43428Withdrawn
- Sponsor
- Erasmus MC
- Start
- Aug 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of aspirin in systemic mastocytosis (SM), sponsored by Erasmus MC. Primary endpoints: Frequency of allergic reactions due to aspirin ingestion and Severity of anaphylaxis. Planned start Aug 2016; status: withdrawn.
02
Drugs
aspirin
03
Conditions
systemic mastocytosis (SM)
Beyond the preview
Go deeper on NL-OMON43428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43428.